Navigation Links
Lilly Reports Third-Quarter 2013 Results
Date:10/23/2013

Amylin.

On a reported basis, the 2013 tax rate is still expected to be approximately 20.5 percent. On a non-GAAP basis, the 2013 tax rate is still expected to be approximately 19.0 percent. Both tax rates for 2013 include the one-time impact associated with the R&D tax credit for 2012 that was recorded in 2013 resulting from the delay in the enactment of the American Taxpayer Relief Act of 2012.

Operating cash flows are still expected to be more than sufficient to allow for capital expenditures now anticipated to be approximately $1.0 billion, fund potential business development activity and pay the company's dividend. In addition, the company has completed its previously-announced $1.5 billion share repurchase program and will soon begin its new $5 billion share repurchase program, which will be completed over time.

Webcast of Conference Call
As previously announced, investors and the general public can access a live webcast of the third-quarter 2013 financial results conference call through a link on Lilly's website at www.lilly.com. The conference call will be held today from 9:00 a.m. to 10:00 a.m. Eastern Daylight Time (EDT) and will be available for replay via the website.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

F-LLY

This press release contains management's current intentions and expectations for the future, all of which are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and S
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
2. Lilly Declares Fourth-Quarter 2013 Dividend
3. Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
4. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
5. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
6. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
7. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
8. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
9. Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
10. Dr. Marschall S. Runge Elected to Lilly Board of Directors
11. Lilly Reports Second-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... BURLINGTON, Mass. , July 31, 2014 ... healthcare funding changes brought about by the ... both reimbursement and prescribing of pharmaceutical therapies. ... (MCOs) cover beneficiaries through new regulations and ... is occurring in the health exchanges—state-based marketplaces ...
(Date:7/31/2014)... Portugal , July 31, 2014 ... Cork, Ireland has successfully passed a pre-approval inspection ... The inspection, carried out by the FDA Consumer Safety Officer, ... planned, started on 21 st July and concluded on ... be compliant with the principles and guidelines of Good Manufacturing ...
(Date:7/31/2014)...  Zacks.com announces the list of stocks featured in the ... the latest news and events impacting stocks and the financial ... BIIB - Free Report ), Gilead (Nasdaq: GILD ... Free Report ), AbbVie (NYSE: ABBV - Free Report ... Today, Zacks is promoting its ,Buy, stock recommendations. ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6
... SHAWNEE, Kan., June 17, 2011 Bayer HealthCare LLC ... of the lawsuit between Bayer and Farnam Companies Inc. ... tick control products.  As part of the settlement, Farnam ... Farnam,s print and online advertising campaign included claims that ...
... 17, 2011 NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank, CEO, received the ... 2011 New England Award in the Medical Devices category. ... extraordinary success in such areas as innovation, financial performance ...
Cached Medicine Technology:Bayer Announces Farnam Companies' Agreement to Halt Disputed Bio Spot® Ads 2NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 2NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 3NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner 4
(Date:7/31/2014)... Cosmetic Town has introduced a secure verification ... will be able to verify their patients before the ... guarantees their authenticity. This will help prospective patients ... information that has been verified to come from a ... Town to filter out fake patients who leave fraudulent ...
(Date:7/31/2014)... 2014 NEWwoodworks, fine woodworking group at ... brand presence with a website dedicated to highlighting their ... has specialized in handcrafted cabinetry, furniture, stairs , ... earned a reputation for taking on the remarkable, challenging ... commonly craft with reclaimed wood, often using near extinct ...
(Date:7/31/2014)... July 31, 2014 US Hair Restoration Founder, ... now be known as Parsa Mohebi Hair Restoration. Since ... of patients in Southern California and around the world, who ... Hills and Orange County. These patients achieved the full benefits ... techniques that were perfected by Dr. Mohebi. They have ...
(Date:7/31/2014)... Daily Gossip indicates in its "Neuropathy Miracle" review ... problem. However, this is not a solution. , The ... Peter Bansby, who decided to reveal his method with ... world find a unique way of overcoming their health ... and cons from a full Neuropathy Miracle review, simply ...
(Date:7/31/2014)... 31, 2014 July 31, 2014- Title Boxing ... celebrate they have launched a Facebook Sweepstakes giving away prizes ... you have to do is visit http://www.facebook.com/titleboxingcoolsprings and ... share with your friends, and for each one that enters, ... “We are so excited to bring such a new and ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town Improves Patient Experience Through Secure Verification of Patients and Doctors 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:US Hair Restoration Becomes Parsa Mohebi Hair Restoration 2Health News:Neuropathy Miracle Review Reveals Peter Bansby's Unique Cure Method 2
... , , WEDNESDAY, May 28 (HealthDay News) -- Two new ... , Almost 15 percent of Americans are constipated at any ... of two reports in the May 29 issue of the ... on the efficacy of the experimental drug prucalopride on 620 ...
... N.Y., May 28 Caribbean People,International Collective Inc (CPIC) ... community event is set for Sunday, June 8th 2008--Caribbean,American ... opening,sunrise ceremony at 9:30 A.M. and then will kick ... at 10:15 A.M. The 5 K Walk will,continue throughout ...
... Sanaa Lathan Celebrates Inspirational Stories of how People ... ENGLEWOOD CLIFFS, N.J., May 28 Skin is,amazing: it covers ... a,symbol of pride, for others it,s a canvas to tell ... to be honored. Skin means something different,to almost everyone you ...
... ANGELES, May 28 Dr. Jeffrey Cummings, Medical,Director ... at UCLA,received the prestigious Ronald and Nancy Reagan ... team devote themselves to, discovering new,treatments and methods ... disorders., In his speech of acceptance at ...
... a world of internet savvy,patients and consumers, everyday tasks ... With a few clicks of the mouse, your patient,can ... even buy,groceries! A patient,s experience with their dentist is ... friendly., With the new Smile Dash Patient Portal ...
... It could mean development of new class of drugs, ... new compound that inhibits HIV protease has been developed by ... which is necessary for HIV replication, is a common target ... first new HIV protease inhibitor compound to be developed in ...
Cached Medicine News:Health News:Two Drugs Show Promise Against Severe Constipation 2Health News:Two Drugs Show Promise Against Severe Constipation 3Health News:Caribbean People International Collective Inc to Host 8th Annual AIDS WALK CARIBBEAN 2Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 2Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 3Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 4Health News:Empowering Your Patients: Smile Dash Portal 'Bridges Gap' Between Dentists and Patients 2Health News:New Compound Slows HIV Replication 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: